This Inari Medical website and all product offerings listed are tailored for the United States only. Please be aware that product availability and regulatory claims may vary in other regions we serve, including Europe, the Middle East, and Africa (EMEA), Asia-Pacific (APAC), and Latin America/Canada. Inari Medical is currently developing separate websites for our products tailored to these other global and regional markets.
One-Year Clinical Outcomes: A CLOUT Registry Analysis
See Results
Outcomes from the ClotTriever Registry show symptom duration may underestimate DVT chronicity
See Results
6-Month DVT Outcomes by Chronicity: Analysis of the Real-World ClotTriever Outcomes Registry
See Results
CLOUT vs. ATTRACT AC PSM
See Results
6-Month Outcomes of Mechanical Thrombectomy for Treating DVT: Analysis from the 500-Patient CLOUT Registry
See Results
Safety and Effectiveness of Mechanical Thrombectomy from the Fully Enrolled CLOUT Registry
See Results
Association Between 30-Day Villalta Scores and Long-Term PTS Incidence and Severity Following Acute DVT
See Results
Mechanical Thrombectomy vs. Pharmacomechanical CDT for the Treatment of Iliofemoral DVT: A Propensity Score Matched Exploratory Analysis of 12 Month Clinical Outcomes
See Results
* ≥75% thrombus removal assessed via Marder score by an independent core laboratory
References:
1. Dexter D, et al. Safety and effectiveness of mechanical thrombectomy from the fully enrolled multicenter, prospective CLOUT registry. J Soc Cardiov Angiog Interv. 2023;2(2):100585.
2. Shaikh A, et al. Six-month outcomes of mechanical thrombectomy for treating deep vein thrombosis: analysis from the 500-patient CLOUT registry. Cardiovasc Intervent Radiol. 2023; 46(11):1571-1580.
3. Dexter, D. Interim two year outcomes from the fully enrolled CLOUT registry. Presented at AVF 2024 (Tampa, FL).
Indications for Use:
The ClotTriever® thrombectomy system is indicated for (1) the non-surgical removal of thrombi and emboli from blood vessels and (2) injection, infusion and/or aspiration of contrast media and other fluids into or from a blood vessel. The ClotTriever thrombectomy system is intended for use in the peripheral, vasculature, including deep vein thrombosis (DVT).
Refer to IFU for complete Indications for Use, contraindications, warnings, and precautions.
Caution:
Federal (USA) law restricts this device to sale by or on the order of a physician.
All trademarks are property of their respective owners.